| 0 |
MITOCHONDRIAL DNA MUTATION |
40 |
0.4651 |
| 1 |
PAROXYSMAL PERCEPTUAL ALTERATION |
21 |
0.3500 |
| 2 |
NEW ONSET REFRACTORY STATUS EPILEPTICUS |
31 |
0.2818 |
| 3 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
473 |
0.2718 |
| 4 |
INTRA-ABDOMINAL PRESSURE INCREASED |
35 |
0.2229 |
| 5 |
CARNITINE DEFICIENCY |
38 |
0.2222 |
| 6 |
FOETAL ANTICONVULSANT SYNDROME |
218 |
0.1838 |
| 7 |
MULTIPLE-DRUG RESISTANCE |
543 |
0.1749 |
| 8 |
CSF OLIGOCLONAL BAND PRESENT |
21 |
0.1615 |
| 9 |
CONGENITAL NOSE MALFORMATION |
77 |
0.1447 |
| 10 |
ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC |
94 |
0.1446 |
| 11 |
EOSINOPHILIC PLEURAL EFFUSION |
43 |
0.1443 |
| 12 |
POSTICTAL PSYCHOSIS |
22 |
0.1410 |
| 13 |
DECREASED EYE CONTACT |
39 |
0.1283 |
| 14 |
HYPERAMMONAEMIA |
628 |
0.1254 |
| 15 |
RENAL FUSION ANOMALY |
19 |
0.1210 |
| 16 |
NECROSIS ISCHAEMIC |
54 |
0.1169 |
| 17 |
MYOCLONIC EPILEPSY |
158 |
0.1041 |
| 18 |
SCHIZOAFFECTIVE DISORDER |
184 |
0.1031 |
| 19 |
LENNOX-GASTAUT SYNDROME |
22 |
0.0969 |
| 20 |
VASCULAR ENCEPHALOPATHY |
27 |
0.0951 |
| 21 |
EPILEPTIC ENCEPHALOPATHY |
21 |
0.0942 |
| 22 |
PROPOFOL INFUSION SYNDROME |
65 |
0.0922 |
| 23 |
FAILURE TO SUSPEND MEDICATION |
19 |
0.0918 |
| 24 |
CONGENITAL ORAL MALFORMATION |
20 |
0.0913 |
| 25 |
NEOVASCULARISATION |
24 |
0.0913 |
| 26 |
POSTICTAL PARALYSIS |
22 |
0.0909 |
| 27 |
SINUS RHYTHM |
38 |
0.0874 |
| 28 |
OPPOSITIONAL DEFIANT DISORDER |
34 |
0.0861 |
| 29 |
SKULL MALFORMATION |
54 |
0.0840 |
| 30 |
PARTIAL SEIZURES WITH SECONDARY GENERALISATION |
39 |
0.0833 |
| 31 |
WITHDRAWAL CATATONIA |
19 |
0.0823 |
| 32 |
OSCILLOPSIA |
21 |
0.0811 |
| 33 |
DYSMORPHISM |
190 |
0.0806 |
| 34 |
ACIDOSIS HYPERCHLORAEMIC |
47 |
0.0791 |
| 35 |
CENTRAL SLEEP APNOEA SYNDROME |
25 |
0.0769 |
| 36 |
PSYCHIATRIC DECOMPENSATION |
142 |
0.0726 |
| 37 |
ANTICONVULSANT DRUG LEVEL INCREASED |
113 |
0.0699 |
| 38 |
ATONIC SEIZURES |
60 |
0.0698 |
| 39 |
SEIZURE CLUSTER |
57 |
0.0688 |
| 40 |
VAGAL NERVE STIMULATOR IMPLANTATION |
21 |
0.0686 |
| 41 |
POSTURAL TREMOR |
20 |
0.0685 |
| 42 |
LOW SET EARS |
28 |
0.0681 |
| 43 |
STATUS EPILEPTICUS |
763 |
0.0675 |
| 44 |
PNEUMATOSIS |
30 |
0.0674 |
| 45 |
PSYCHOGENIC SEIZURE |
62 |
0.0663 |
| 46 |
PSYCHOMOTOR SKILLS IMPAIRED |
172 |
0.0656 |
| 47 |
RESTING TREMOR |
42 |
0.0650 |
| 48 |
MENINGOMYELOCELE |
39 |
0.0650 |
| 49 |
EXPRESSIVE LANGUAGE DISORDER |
18 |
0.0632 |
| 50 |
TONIC CONVULSION |
88 |
0.0621 |
| 51 |
ASOCIAL BEHAVIOUR |
20 |
0.0619 |
| 52 |
CONGENITAL FOOT MALFORMATION |
28 |
0.0617 |
| 53 |
FANCONI SYNDROME |
87 |
0.0615 |
| 54 |
CHANGE IN SEIZURE PRESENTATION |
39 |
0.0603 |
| 55 |
ANTIPSYCHOTIC DRUG LEVEL DECREASED |
32 |
0.0603 |
| 56 |
PLAGIOCEPHALY |
30 |
0.0601 |
| 57 |
HYPERTELORISM OF ORBIT |
25 |
0.0598 |
| 58 |
CHOREOATHETOSIS |
40 |
0.0589 |
| 59 |
CEREBELLAR ATROPHY |
51 |
0.0579 |
| 60 |
ANTICONVULSANT DRUG LEVEL DECREASED |
81 |
0.0573 |
| 61 |
ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC |
43 |
0.0571 |
| 62 |
DELUSION OF GRANDEUR |
25 |
0.0557 |
| 63 |
INFANTILE SPASMS |
40 |
0.0553 |
| 64 |
PETIT MAL EPILEPSY |
279 |
0.0546 |
| 65 |
LIMB MALFORMATION |
43 |
0.0544 |
| 66 |
SYNDACTYLY |
45 |
0.0542 |
| 67 |
BLOOD GASES ABNORMAL |
29 |
0.0538 |
| 68 |
HYPOSPADIAS |
105 |
0.0504 |
| 69 |
MOTOR DEVELOPMENTAL DELAY |
29 |
0.0502 |
| 70 |
EAR MALFORMATION |
23 |
0.0497 |
| 71 |
FOCAL DYSCOGNITIVE SEIZURES |
56 |
0.0492 |
| 72 |
DROP ATTACKS |
29 |
0.0487 |
| 73 |
INTELLECTUAL DISABILITY |
74 |
0.0487 |
| 74 |
DEVELOPMENTAL HIP DYSPLASIA |
40 |
0.0481 |
| 75 |
AMMONIA INCREASED |
232 |
0.0454 |
| 76 |
CRANIOSYNOSTOSIS |
39 |
0.0450 |
| 77 |
SUDDEN UNEXPLAINED DEATH IN EPILEPSY |
24 |
0.0448 |
| 78 |
DRUG LEVEL CHANGED |
28 |
0.0444 |
| 79 |
DYSPRAXIA |
25 |
0.0443 |
| 80 |
NEUROLEPTIC MALIGNANT SYNDROME |
520 |
0.0438 |
| 81 |
NEURODEVELOPMENTAL DISORDER |
29 |
0.0429 |
| 82 |
CRYPTORCHISM |
48 |
0.0427 |
| 83 |
DYSMETRIA |
25 |
0.0414 |
| 84 |
SPINA BIFIDA |
85 |
0.0408 |
| 85 |
PSYCHOMOTOR RETARDATION |
113 |
0.0402 |
| 86 |
CATATONIA |
211 |
0.0401 |
| 87 |
PLEOCYTOSIS |
23 |
0.0395 |
| 88 |
CONGENITAL HAND MALFORMATION |
27 |
0.0394 |
| 89 |
OCULOGYRIC CRISIS |
83 |
0.0386 |
| 90 |
DRUG WITHDRAWAL CONVULSIONS |
67 |
0.0376 |
| 91 |
PLEUROTHOTONUS |
34 |
0.0376 |
| 92 |
CLONIC CONVULSION |
27 |
0.0369 |
| 93 |
PARTIAL SEIZURES |
193 |
0.0368 |
| 94 |
DRUG-DISEASE INTERACTION |
27 |
0.0368 |
| 95 |
DEPRESSIVE SYMPTOM |
129 |
0.0366 |
| 96 |
ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC |
32 |
0.0359 |
| 97 |
SPEECH DISORDER DEVELOPMENTAL |
101 |
0.0352 |
| 98 |
HYPERCHLORAEMIA |
22 |
0.0344 |
| 99 |
ANTIPSYCHOTIC DRUG LEVEL INCREASED |
96 |
0.0341 |
| 100 |
BEHAVIOUR DISORDER |
180 |
0.0332 |
| 101 |
ELECTROENCEPHALOGRAM ABNORMAL |
104 |
0.0329 |
| 102 |
ASTERIXIS |
35 |
0.0329 |
| 103 |
ARNOLD-CHIARI MALFORMATION |
31 |
0.0325 |
| 104 |
DEPRESSION SUICIDAL |
111 |
0.0320 |
| 105 |
MICROCEPHALY |
41 |
0.0320 |
| 106 |
ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC |
22 |
0.0318 |
| 107 |
GAZE PALSY |
53 |
0.0311 |
| 108 |
PARKINSONISM |
300 |
0.0307 |
| 109 |
DRUG LEVEL INCREASED |
504 |
0.0304 |
| 110 |
POLYDACTYLY |
35 |
0.0302 |
| 111 |
HYPERNATRAEMIA |
150 |
0.0301 |
| 112 |
PARADOXICAL DRUG REACTION |
110 |
0.0299 |
| 113 |
COMPLEX PARTIAL SEIZURES |
33 |
0.0297 |
| 114 |
LIP DISORDER |
56 |
0.0295 |
| 115 |
PERSECUTORY DELUSION |
73 |
0.0292 |
| 116 |
MITOCHONDRIAL TOXICITY |
24 |
0.0292 |
| 117 |
GENERALISED TONIC-CLONIC SEIZURE |
477 |
0.0288 |
| 118 |
TOXIC ENCEPHALOPATHY |
146 |
0.0288 |
| 119 |
EXCESSIVE EYE BLINKING |
42 |
0.0284 |
| 120 |
CEREBRAL ATROPHY |
110 |
0.0276 |
| 121 |
DELUSIONAL DISORDER, UNSPECIFIED TYPE |
20 |
0.0267 |
| 122 |
STEREOTYPY |
25 |
0.0265 |
| 123 |
TEARFULNESS |
114 |
0.0265 |
| 124 |
TALIPES |
82 |
0.0264 |
| 125 |
COGWHEEL RIGIDITY |
27 |
0.0257 |
| 126 |
MULTIPLE DRUG THERAPY |
19 |
0.0252 |
| 127 |
HYPERKINESIA |
53 |
0.0250 |
| 128 |
STUPOR |
80 |
0.0249 |
| 129 |
ATAXIA |
292 |
0.0246 |
| 130 |
SUBILEUS |
50 |
0.0240 |
| 131 |
DRUG LEVEL BELOW THERAPEUTIC |
132 |
0.0239 |
| 132 |
NYSTAGMUS |
126 |
0.0237 |
| 133 |
AUTISM |
24 |
0.0236 |
| 134 |
THERAPEUTIC PRODUCT CROSS-REACTIVITY |
21 |
0.0235 |
| 135 |
SIMPLE PARTIAL SEIZURES |
19 |
0.0235 |
| 136 |
SALIVARY HYPERSECRETION |
234 |
0.0234 |
| 137 |
GENE MUTATION |
45 |
0.0227 |
| 138 |
DRUG INTERACTION |
3570 |
0.0225 |
| 139 |
CLEFT LIP AND PALATE |
25 |
0.0224 |
| 140 |
TONIC CLONIC MOVEMENTS |
29 |
0.0223 |
| 141 |
PSYCHOTIC SYMPTOM |
46 |
0.0223 |
| 142 |
CLEFT PALATE |
43 |
0.0222 |
| 143 |
MEDICATION OVERUSE HEADACHE |
19 |
0.0222 |
| 144 |
EPILEPSY |
679 |
0.0222 |
| 145 |
FEBRILE CONVULSION |
27 |
0.0221 |
| 146 |
IDIOSYNCRATIC DRUG REACTION |
21 |
0.0214 |
| 147 |
PYLORIC STENOSIS |
18 |
0.0213 |
| 148 |
ACCIDENTAL DEATH |
39 |
0.0210 |
| 149 |
METABOLIC ENCEPHALOPATHY |
63 |
0.0210 |
| 150 |
MUCOSAL ULCERATION |
21 |
0.0209 |
| 151 |
MYOCLONUS |
248 |
0.0208 |
| 152 |
GLYCOSURIA |
28 |
0.0207 |
| 153 |
EOSINOPHIL COUNT DECREASED |
49 |
0.0206 |
| 154 |
DISINHIBITION |
33 |
0.0205 |
| 155 |
ASTIGMATISM |
31 |
0.0204 |
| 156 |
GINGIVAL HYPERTROPHY |
31 |
0.0204 |
| 157 |
BRUGADA SYNDROME |
21 |
0.0203 |
| 158 |
MULTIPLE CONGENITAL ABNORMALITIES |
29 |
0.0201 |
| 159 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
77 |
0.0201 |
| 160 |
FEEDING DISORDER NEONATAL |
21 |
0.0201 |
| 161 |
QUADRIPARESIS |
33 |
0.0199 |
| 162 |
HYPOTONIA NEONATAL |
31 |
0.0198 |
| 163 |
INTESTINAL ISCHAEMIA |
109 |
0.0198 |
| 164 |
HYPOMANIA |
72 |
0.0196 |
| 165 |
CEREBRAL VENTRICLE DILATATION |
22 |
0.0191 |
| 166 |
LEARNING DISORDER |
45 |
0.0186 |
| 167 |
DRUG RESISTANCE |
478 |
0.0186 |
| 168 |
MUTISM |
27 |
0.0186 |
| 169 |
NEPHROCALCINOSIS |
22 |
0.0185 |
| 170 |
POSTICTAL STATE |
19 |
0.0183 |
| 171 |
NEPHROGENIC DIABETES INSIPIDUS |
21 |
0.0182 |
| 172 |
SUBSTANCE USE |
28 |
0.0179 |
| 173 |
VENTRICULAR SEPTAL DEFECT |
101 |
0.0176 |
| 174 |
MYOCARDITIS |
201 |
0.0175 |
| 175 |
HYPERTROPHIC CARDIOMYOPATHY |
27 |
0.0174 |
| 176 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
29 |
0.0174 |
| 177 |
DISTRACTIBILITY |
20 |
0.0173 |
| 178 |
MULTIPLE DRUG OVERDOSE |
86 |
0.0173 |
| 179 |
SEIZURE |
1978 |
0.0171 |
| 180 |
WRONG PATIENT RECEIVED PRODUCT |
50 |
0.0171 |
| 181 |
SEDATION |
445 |
0.0170 |
| 182 |
ENCEPHALITIS AUTOIMMUNE |
22 |
0.0167 |
| 183 |
HYPOTHERMIA |
169 |
0.0167 |
| 184 |
PSYCHOTIC DISORDER |
487 |
0.0165 |
| 185 |
BIPOLAR I DISORDER |
36 |
0.0164 |
| 186 |
MONOCYTE COUNT DECREASED |
20 |
0.0164 |
| 187 |
PROCALCITONIN INCREASED |
19 |
0.0162 |
| 188 |
ILEUS PARALYTIC |
71 |
0.0159 |
| 189 |
COMPLETED SUICIDE |
1311 |
0.0157 |
| 190 |
MUSCLE RIGIDITY |
188 |
0.0157 |
| 191 |
ANTICHOLINERGIC SYNDROME |
25 |
0.0157 |
| 192 |
LIP HAEMORRHAGE |
20 |
0.0157 |
| 193 |
SEDATION COMPLICATION |
40 |
0.0157 |
| 194 |
CHOREA |
27 |
0.0157 |
| 195 |
PUPILLARY REFLEX IMPAIRED |
29 |
0.0157 |
| 196 |
HYPERLACTACIDAEMIA |
42 |
0.0156 |
| 197 |
SUBSTANCE-INDUCED PSYCHOTIC DISORDER |
35 |
0.0156 |
| 198 |
EDUCATIONAL PROBLEM |
26 |
0.0156 |
| 199 |
RENAL TUBULAR ACIDOSIS |
34 |
0.0156 |
| 200 |
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
50 |
0.0154 |
| 201 |
POSTURE ABNORMAL |
50 |
0.0154 |
| 202 |
SCHIZOPHRENIA |
186 |
0.0153 |
| 203 |
LANGUAGE DISORDER |
33 |
0.0153 |
| 204 |
AUTISM SPECTRUM DISORDER |
84 |
0.0152 |
| 205 |
DEVELOPMENTAL DELAY |
136 |
0.0151 |
| 206 |
ENCEPHALOPATHY |
370 |
0.0151 |
| 207 |
NECROTISING COLITIS |
19 |
0.0150 |
| 208 |
SUPERINFECTION |
22 |
0.0147 |
| 209 |
DRUG LEVEL DECREASED |
149 |
0.0146 |
| 210 |
DIABETES INSIPIDUS |
35 |
0.0145 |
| 211 |
BLOOD LACTIC ACID INCREASED |
76 |
0.0144 |
| 212 |
GRAND MAL CONVULSION |
133 |
0.0144 |
| 213 |
PATENT DUCTUS ARTERIOSUS |
57 |
0.0143 |
| 214 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
38 |
0.0143 |
| 215 |
IMPULSIVE BEHAVIOUR |
53 |
0.0141 |
| 216 |
SUSPECTED SUICIDE |
66 |
0.0141 |
| 217 |
BLOOD PH DECREASED |
24 |
0.0140 |
| 218 |
RESPIRATORY ACIDOSIS |
55 |
0.0140 |
| 219 |
HYPOTONIA |
139 |
0.0139 |
| 220 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
543 |
0.0137 |
| 221 |
AGGRESSION |
684 |
0.0137 |
| 222 |
MANIA |
221 |
0.0134 |
| 223 |
HAEMANGIOMA |
31 |
0.0134 |
| 224 |
BRADYPNOEA |
36 |
0.0133 |
| 225 |
ILLUSION |
22 |
0.0133 |
| 226 |
CEREBELLAR SYNDROME |
29 |
0.0132 |
| 227 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
340 |
0.0132 |
| 228 |
PSYCHOMOTOR HYPERACTIVITY |
217 |
0.0131 |
| 229 |
HOMICIDAL IDEATION |
53 |
0.0131 |
| 230 |
HYPOREFLEXIA |
25 |
0.0130 |
| 231 |
ATRIAL SEPTAL DEFECT |
109 |
0.0130 |
| 232 |
POISONING |
162 |
0.0129 |
| 233 |
ELECTROCARDIOGRAM QT PROLONGED |
462 |
0.0128 |
| 234 |
APRAXIA |
19 |
0.0128 |
| 235 |
PUPIL FIXED |
22 |
0.0127 |
| 236 |
MATERNAL DRUGS AFFECTING FOETUS |
97 |
0.0126 |
| 237 |
INHIBITORY DRUG INTERACTION |
20 |
0.0126 |
| 238 |
NEUROLOGICAL DECOMPENSATION |
29 |
0.0125 |
| 239 |
CLONUS |
34 |
0.0124 |
| 240 |
STARING |
30 |
0.0124 |
| 241 |
HYPERTONIA |
71 |
0.0124 |
| 242 |
TORTICOLLIS |
26 |
0.0123 |
| 243 |
EXTRAPYRAMIDAL DISORDER |
303 |
0.0122 |
| 244 |
RESPIRATORY DEPRESSION |
148 |
0.0121 |
| 245 |
TOXIC EPIDERMAL NECROLYSIS |
183 |
0.0120 |
| 246 |
TOXICITY TO VARIOUS AGENTS |
2024 |
0.0120 |
| 247 |
FANCONI SYNDROME ACQUIRED |
21 |
0.0120 |
| 248 |
STILLBIRTH |
57 |
0.0118 |
| 249 |
PANCREATITIS NECROTISING |
27 |
0.0117 |
| 250 |
PNEUMONIA PSEUDOMONAL |
18 |
0.0117 |
| 251 |
BRAIN OEDEMA |
147 |
0.0116 |
| 252 |
HYPERREFLEXIA |
40 |
0.0115 |
| 253 |
FOETAL EXPOSURE DURING PREGNANCY |
931 |
0.0114 |
| 254 |
PARANOIA |
197 |
0.0114 |
| 255 |
MENTAL STATUS CHANGES |
317 |
0.0114 |
| 256 |
DELIRIUM |
395 |
0.0114 |
| 257 |
BRAIN DEATH |
35 |
0.0113 |
| 258 |
PNEUMONIA ASPIRATION |
282 |
0.0113 |
| 259 |
COMA |
537 |
0.0113 |
| 260 |
MULTIPLE DRUG OVERDOSE INTENTIONAL |
36 |
0.0112 |
| 261 |
BRADYKINESIA |
66 |
0.0112 |
| 262 |
METABOLIC ACIDOSIS |
355 |
0.0111 |
| 263 |
DRUG TOXICITY |
151 |
0.0111 |
| 264 |
HYPOVENTILATION |
36 |
0.0110 |
| 265 |
PRIAPISM |
38 |
0.0110 |
| 266 |
METABOLIC SYNDROME |
18 |
0.0109 |
| 267 |
STEVENS-JOHNSON SYNDROME |
242 |
0.0109 |
| 268 |
DISORGANISED SPEECH |
20 |
0.0108 |
| 269 |
ALTERED STATE OF CONSCIOUSNESS |
234 |
0.0108 |
| 270 |
ACUTE HEPATIC FAILURE |
147 |
0.0107 |
| 271 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
55 |
0.0107 |
| 272 |
COMA SCALE ABNORMAL |
31 |
0.0107 |
| 273 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
31 |
0.0106 |
| 274 |
BLOOD BICARBONATE DECREASED |
20 |
0.0106 |
| 275 |
LOGORRHOEA |
37 |
0.0105 |
| 276 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
298 |
0.0103 |
| 277 |
HALLUCINATION, AUDITORY |
164 |
0.0103 |
| 278 |
ANAEMIA MACROCYTIC |
22 |
0.0103 |
| 279 |
HYPERCAPNIA |
31 |
0.0103 |
| 280 |
HYPERTHERMIA |
78 |
0.0102 |
| 281 |
STRABISMUS |
30 |
0.0102 |
| 282 |
DISTURBANCE IN SOCIAL BEHAVIOUR |
24 |
0.0102 |
| 283 |
DRUG LEVEL ABOVE THERAPEUTIC |
46 |
0.0100 |
| 284 |
GASTROINTESTINAL NECROSIS |
29 |
0.0099 |
| 285 |
HAEMODYNAMIC INSTABILITY |
75 |
0.0098 |
| 286 |
COMMUNICATION DISORDER |
37 |
0.0097 |
| 287 |
AKATHISIA |
132 |
0.0097 |
| 288 |
AKINESIA |
20 |
0.0096 |
| 289 |
ENURESIS |
39 |
0.0096 |
| 290 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
99 |
0.0096 |
| 291 |
BLOOD SODIUM INCREASED |
26 |
0.0096 |
| 292 |
ABNORMAL BEHAVIOUR |
380 |
0.0096 |
| 293 |
SEROTONIN SYNDROME |
183 |
0.0095 |
| 294 |
MOTOR DYSFUNCTION |
97 |
0.0095 |
| 295 |
COGNITIVE DISORDER |
438 |
0.0094 |
| 296 |
HEART DISEASE CONGENITAL |
33 |
0.0093 |
| 297 |
COORDINATION ABNORMAL |
130 |
0.0093 |
| 298 |
ACUTE PSYCHOSIS |
23 |
0.0093 |
| 299 |
DYSARTHRIA |
350 |
0.0093 |
| 300 |
LEUKOCYTOSIS |
168 |
0.0093 |
| 301 |
AFFECT LABILITY |
88 |
0.0091 |
| 302 |
HYPERACUSIS |
34 |
0.0091 |
| 303 |
CELL DEATH |
18 |
0.0091 |
| 304 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
80 |
0.0090 |
| 305 |
BRAIN HERNIATION |
27 |
0.0090 |
| 306 |
CONVULSION |
515 |
0.0090 |
| 307 |
DELUSION |
138 |
0.0089 |
| 308 |
POLYDIPSIA |
35 |
0.0088 |
| 309 |
AFFECTIVE DISORDER |
69 |
0.0088 |
| 310 |
FAECALOMA |
48 |
0.0088 |
| 311 |
ABDOMINAL TENDERNESS |
43 |
0.0087 |
| 312 |
RASH MORBILLIFORM |
24 |
0.0086 |
| 313 |
AGITATION |
635 |
0.0086 |
| 314 |
INTENTIONAL OVERDOSE |
548 |
0.0085 |
| 315 |
PANCREATITIS ACUTE |
191 |
0.0085 |
| 316 |
HYPERPROLACTINAEMIA |
55 |
0.0085 |
| 317 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
30 |
0.0085 |
| 318 |
SUICIDAL BEHAVIOUR |
35 |
0.0084 |
| 319 |
BRUXISM |
45 |
0.0083 |
| 320 |
MONOCYTE COUNT INCREASED |
30 |
0.0083 |
| 321 |
DROOLING |
57 |
0.0082 |
| 322 |
AREFLEXIA |
22 |
0.0082 |
| 323 |
NEUTROPHIL COUNT INCREASED |
84 |
0.0082 |
| 324 |
BIPOLAR DISORDER |
89 |
0.0082 |
| 325 |
RENAL TUBULAR DISORDER |
23 |
0.0082 |
| 326 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
78 |
0.0082 |
| 327 |
SOPOR |
108 |
0.0081 |
| 328 |
MEDICATION RESIDUE |
21 |
0.0081 |
| 329 |
DYSTONIA |
158 |
0.0081 |
| 330 |
ACIDOSIS |
62 |
0.0081 |
| 331 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
21 |
0.0080 |
| 332 |
VENTRICULAR ARRHYTHMIA |
29 |
0.0079 |
| 333 |
HEPATOTOXICITY |
175 |
0.0079 |
| 334 |
CONJUNCTIVAL HYPERAEMIA |
28 |
0.0078 |
| 335 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
33 |
0.0078 |
| 336 |
CARDIO-RESPIRATORY ARREST |
325 |
0.0078 |
| 337 |
EOSINOPHILIA |
135 |
0.0077 |
| 338 |
RED CELL DISTRIBUTION WIDTH INCREASED |
32 |
0.0077 |
| 339 |
ANTINUCLEAR ANTIBODY POSITIVE |
25 |
0.0077 |
| 340 |
UNRESPONSIVE TO STIMULI |
198 |
0.0077 |
| 341 |
THERAPY PARTIAL RESPONDER |
119 |
0.0076 |
| 342 |
PSYCHIATRIC SYMPTOM |
56 |
0.0076 |
| 343 |
MYOPIA |
18 |
0.0076 |
| 344 |
TRISMUS |
39 |
0.0075 |
| 345 |
PRESCRIBED OVERDOSE |
146 |
0.0075 |
| 346 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
413 |
0.0075 |
| 347 |
POISONING DELIBERATE |
70 |
0.0074 |
| 348 |
RHABDOMYOLYSIS |
307 |
0.0074 |
| 349 |
BRADYPHRENIA |
48 |
0.0073 |
| 350 |
COAGULOPATHY |
122 |
0.0073 |
| 351 |
APNOEA |
57 |
0.0073 |
| 352 |
RESPIRATORY ARREST |
201 |
0.0073 |
| 353 |
OTITIS MEDIA |
24 |
0.0073 |
| 354 |
SINUS TACHYCARDIA |
103 |
0.0072 |
| 355 |
LEFT VENTRICULAR HYPERTROPHY |
31 |
0.0072 |
| 356 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
56 |
0.0072 |
| 357 |
MIOSIS |
57 |
0.0071 |
| 358 |
SUICIDE ATTEMPT |
430 |
0.0071 |
| 359 |
HYPERTRANSAMINASAEMIA |
49 |
0.0070 |
| 360 |
GRANULOCYTOPENIA |
40 |
0.0070 |
| 361 |
DISORIENTATION |
278 |
0.0070 |
| 362 |
LEARNING DISABILITY |
37 |
0.0069 |
| 363 |
ENCEPHALITIS |
48 |
0.0069 |
| 364 |
TREATMENT NONCOMPLIANCE |
378 |
0.0069 |
| 365 |
HEPATIC FAILURE |
208 |
0.0069 |
| 366 |
METABOLIC DISORDER |
40 |
0.0069 |
| 367 |
GASTROINTESTINAL SOUNDS ABNORMAL |
34 |
0.0069 |
| 368 |
POTENTIATING DRUG INTERACTION |
23 |
0.0068 |
| 369 |
RESPIRATORY RATE DECREASED |
21 |
0.0067 |
| 370 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
317 |
0.0066 |
| 371 |
BLOOD PHOSPHORUS INCREASED |
18 |
0.0066 |
| 372 |
BLOOD PROLACTIN INCREASED |
31 |
0.0066 |
| 373 |
LYMPHOCYTE COUNT INCREASED |
21 |
0.0064 |
| 374 |
SOMNOLENCE |
1293 |
0.0064 |
| 375 |
HALLUCINATIONS, MIXED |
27 |
0.0064 |
| 376 |
DYSGRAPHIA |
42 |
0.0064 |
| 377 |
HYPOPNOEA |
22 |
0.0063 |
| 378 |
DYSPHORIA |
32 |
0.0063 |
| 379 |
TROPONIN INCREASED |
48 |
0.0063 |
| 380 |
THERAPEUTIC AGENT TOXICITY |
21 |
0.0063 |
| 381 |
REBOUND EFFECT |
71 |
0.0063 |
| 382 |
SHOCK |
144 |
0.0063 |
| 383 |
APATHY |
91 |
0.0062 |
| 384 |
INTENTIONAL SELF-INJURY |
126 |
0.0062 |
| 385 |
SOCIAL AVOIDANT BEHAVIOUR |
36 |
0.0062 |
| 386 |
MENTAL IMPAIRMENT |
150 |
0.0062 |
| 387 |
MYDRIASIS |
79 |
0.0062 |
| 388 |
SUDDEN DEATH |
65 |
0.0061 |
| 389 |
BUNDLE BRANCH BLOCK RIGHT |
28 |
0.0061 |
| 390 |
FOOT DEFORMITY |
67 |
0.0060 |
| 391 |
HYPERVENTILATION |
35 |
0.0060 |
| 392 |
RASH MACULO-PAPULAR |
134 |
0.0060 |
| 393 |
TACHYPNOEA |
81 |
0.0060 |
| 394 |
STREPTOCOCCAL INFECTION |
33 |
0.0059 |
| 395 |
FIBRIN D DIMER INCREASED |
21 |
0.0059 |
| 396 |
TREATMENT FAILURE |
486 |
0.0059 |
| 397 |
EUPHORIC MOOD |
60 |
0.0059 |
| 398 |
HYPERTRIGLYCERIDAEMIA |
34 |
0.0058 |
| 399 |
TRANSAMINASES INCREASED |
129 |
0.0058 |
| 400 |
HYPOALBUMINAEMIA |
45 |
0.0058 |
| 401 |
IRRITABILITY |
348 |
0.0058 |
| 402 |
NEUROLOGICAL SYMPTOM |
33 |
0.0058 |
| 403 |
ASPIRATION |
63 |
0.0057 |
| 404 |
THROMBOCYTOPENIA |
642 |
0.0057 |
| 405 |
TORSADE DE POINTES |
45 |
0.0057 |
| 406 |
CARDIOMEGALY |
70 |
0.0057 |
| 407 |
HYDROCEPHALUS |
31 |
0.0057 |
| 408 |
DYSKINESIA |
231 |
0.0057 |
| 409 |
HEPATITIS CHOLESTATIC |
34 |
0.0056 |
| 410 |
ILEUS |
70 |
0.0056 |
| 411 |
MAJOR DEPRESSION |
41 |
0.0056 |
| 412 |
HYPOCALCAEMIA |
106 |
0.0056 |
| 413 |
RESTLESSNESS |
203 |
0.0055 |
| 414 |
DRUG-INDUCED LIVER INJURY |
174 |
0.0055 |
| 415 |
LEUKOPENIA |
276 |
0.0055 |
| 416 |
REFUSAL OF TREATMENT BY PATIENT |
36 |
0.0055 |
| 417 |
HEPATOMEGALY |
54 |
0.0055 |
| 418 |
SPEECH DISORDER |
287 |
0.0055 |
| 419 |
NEUTROPHILIA |
31 |
0.0054 |
| 420 |
BLOOD ALBUMIN DECREASED |
43 |
0.0054 |
| 421 |
INCOHERENT |
35 |
0.0054 |
| 422 |
DEPRESSION |
1230 |
0.0054 |
| 423 |
DRUG EXPOSURE DURING PREGNANCY |
182 |
0.0053 |
| 424 |
ABORTION SPONTANEOUS |
214 |
0.0053 |
| 425 |
SCREAMING |
34 |
0.0053 |
| 426 |
WRONG PRODUCT ADMINISTERED |
36 |
0.0053 |
| 427 |
HYPONATRAEMIA |
300 |
0.0053 |
| 428 |
SCOLIOSIS |
33 |
0.0053 |
| 429 |
DYSLIPIDAEMIA |
27 |
0.0053 |
| 430 |
TYPE 1 DIABETES MELLITUS |
32 |
0.0053 |
| 431 |
HALLUCINATION, VISUAL |
112 |
0.0053 |
| 432 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
24 |
0.0053 |
| 433 |
EYE MOVEMENT DISORDER |
36 |
0.0053 |
| 434 |
APLASIA PURE RED CELL |
18 |
0.0052 |
| 435 |
PERIORBITAL OEDEMA |
27 |
0.0052 |
| 436 |
PRODUCT PREPARATION ISSUE |
34 |
0.0052 |
| 437 |
HYPOKINESIA |
75 |
0.0052 |
| 438 |
CARDIAC ARREST |
425 |
0.0051 |
| 439 |
HYPOPHOSPHATAEMIA |
38 |
0.0051 |
| 440 |
RHINOVIRUS INFECTION |
20 |
0.0051 |
| 441 |
OBESITY |
81 |
0.0051 |
| 442 |
AGRANULOCYTOSIS |
94 |
0.0051 |
| 443 |
CONGENITAL ANOMALY |
39 |
0.0050 |
| 444 |
HEPATIC ENCEPHALOPATHY |
47 |
0.0050 |
| 445 |
DISTURBANCE IN ATTENTION |
271 |
0.0050 |
| 446 |
HYPOVOLAEMIC SHOCK |
24 |
0.0050 |
| 447 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
110 |
0.0050 |
| 448 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
25 |
0.0049 |
| 449 |
TENSION |
30 |
0.0049 |
| 450 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
139 |
0.0049 |
| 451 |
LETHARGY |
282 |
0.0049 |
| 452 |
WHITE BLOOD CELL COUNT INCREASED |
188 |
0.0049 |
| 453 |
BRAIN INJURY |
49 |
0.0049 |
| 454 |
ASPARTATE AMINOTRANSFERASE INCREASED |
259 |
0.0049 |
| 455 |
VENTRICULAR FIBRILLATION |
54 |
0.0049 |
| 456 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
21 |
0.0048 |
| 457 |
PULSELESS ELECTRICAL ACTIVITY |
20 |
0.0048 |
| 458 |
HEPATIC NECROSIS |
18 |
0.0048 |
| 459 |
ATELECTASIS |
46 |
0.0048 |
| 460 |
SUICIDAL IDEATION |
431 |
0.0047 |
| 461 |
PROTHROMBIN TIME PROLONGED |
28 |
0.0047 |
| 462 |
NEUROTOXICITY |
82 |
0.0047 |
| 463 |
INTRACRANIAL PRESSURE INCREASED |
26 |
0.0047 |
| 464 |
HAEMODIALYSIS |
39 |
0.0046 |
| 465 |
DIPLOPIA |
120 |
0.0046 |
| 466 |
EXPOSURE DURING PREGNANCY |
286 |
0.0046 |
| 467 |
THERAPY NON-RESPONDER |
205 |
0.0046 |
| 468 |
SINUS BRADYCARDIA |
44 |
0.0045 |
| 469 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
34 |
0.0045 |
| 470 |
LOW BIRTH WEIGHT BABY |
36 |
0.0045 |
| 471 |
URINARY INCONTINENCE |
134 |
0.0045 |
| 472 |
CIRCULATORY COLLAPSE |
77 |
0.0045 |
| 473 |
HYPERPHAGIA |
18 |
0.0045 |
| 474 |
EPSTEIN-BARR VIRUS INFECTION |
28 |
0.0045 |
| 475 |
OVERDOSE |
955 |
0.0044 |
| 476 |
THROMBOTIC MICROANGIOPATHY |
43 |
0.0044 |
| 477 |
STAPHYLOCOCCAL BACTERAEMIA |
19 |
0.0044 |
| 478 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
68 |
0.0043 |
| 479 |
MULTI-ORGAN FAILURE |
74 |
0.0043 |
| 480 |
HYPERPYREXIA |
18 |
0.0042 |
| 481 |
ALANINE AMINOTRANSFERASE INCREASED |
261 |
0.0042 |
| 482 |
ELECTROLYTE IMBALANCE |
49 |
0.0042 |
| 483 |
APHASIA |
127 |
0.0042 |
| 484 |
GESTATIONAL DIABETES |
20 |
0.0042 |
| 485 |
CEREBRAL DISORDER |
31 |
0.0042 |
| 486 |
LARGE INTESTINE PERFORATION |
29 |
0.0042 |
| 487 |
CARDIAC MURMUR |
36 |
0.0042 |
| 488 |
TREMOR |
690 |
0.0042 |
| 489 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
71 |
0.0041 |
| 490 |
CAESAREAN SECTION |
48 |
0.0041 |
| 491 |
TACHYCARDIA |
366 |
0.0041 |
| 492 |
INGUINAL HERNIA |
25 |
0.0041 |
| 493 |
PURPURA |
36 |
0.0041 |
| 494 |
ANURIA |
35 |
0.0041 |
| 495 |
GALACTORRHOEA |
26 |
0.0040 |
| 496 |
SMALL FOR DATES BABY |
20 |
0.0040 |
| 497 |
TRICUSPID VALVE INCOMPETENCE |
32 |
0.0040 |
| 498 |
OLIGURIA |
25 |
0.0040 |
| 499 |
PANCYTOPENIA |
225 |
0.0040 |
| 500 |
HYDRONEPHROSIS |
30 |
0.0040 |
| 501 |
RESPIRATORY DISTRESS |
110 |
0.0040 |
| 502 |
C-REACTIVE PROTEIN INCREASED |
145 |
0.0040 |
| 503 |
HEPATIC STEATOSIS |
74 |
0.0040 |
| 504 |
ORTHOSTATIC HYPOTENSION |
69 |
0.0040 |
| 505 |
FAECAL INCONTINENCE |
19 |
0.0040 |
| 506 |
ELECTROCARDIOGRAM ABNORMAL |
31 |
0.0039 |
| 507 |
HYPOXIA |
139 |
0.0039 |
| 508 |
ECCHYMOSIS |
27 |
0.0039 |
| 509 |
ABORTION INDUCED |
37 |
0.0039 |
| 510 |
BRADYCARDIA |
207 |
0.0039 |
| 511 |
OSTEOPENIA |
59 |
0.0039 |
| 512 |
DERMATITIS BULLOUS |
28 |
0.0039 |
| 513 |
RESPIRATORY FAILURE |
282 |
0.0039 |
| 514 |
NO THERAPEUTIC RESPONSE |
47 |
0.0039 |
| 515 |
DISEASE RECURRENCE |
182 |
0.0038 |
| 516 |
SUBSTANCE ABUSE |
31 |
0.0038 |
| 517 |
PANCREATITIS |
201 |
0.0038 |
| 518 |
DERMATITIS EXFOLIATIVE |
19 |
0.0038 |
| 519 |
MATERNAL EXPOSURE DURING PREGNANCY |
337 |
0.0038 |
| 520 |
TOXIC SKIN ERUPTION |
38 |
0.0038 |
| 521 |
KLEBSIELLA INFECTION |
19 |
0.0038 |
| 522 |
TUBULOINTERSTITIAL NEPHRITIS |
70 |
0.0037 |
| 523 |
EOSINOPHIL COUNT INCREASED |
31 |
0.0037 |
| 524 |
CONFUSIONAL STATE |
599 |
0.0037 |
| 525 |
THINKING ABNORMAL |
69 |
0.0037 |
| 526 |
HYPOTHYROIDISM |
118 |
0.0037 |
| 527 |
NEUTROPENIA |
502 |
0.0037 |
| 528 |
CYANOSIS |
58 |
0.0037 |
| 529 |
PERICARDIAL EFFUSION |
85 |
0.0037 |
| 530 |
LIVER INJURY |
90 |
0.0037 |
| 531 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
91 |
0.0037 |
| 532 |
FAILURE TO THRIVE |
19 |
0.0037 |
| 533 |
SUPRAVENTRICULAR TACHYCARDIA |
35 |
0.0037 |
| 534 |
DEPRESSED MOOD |
193 |
0.0036 |
| 535 |
HEPATIC ENZYME ABNORMAL |
18 |
0.0036 |
| 536 |
INCONTINENCE |
38 |
0.0036 |
| 537 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
255 |
0.0036 |
| 538 |
DRUG ABUSE |
298 |
0.0036 |
| 539 |
HYPOTENSION |
718 |
0.0036 |
| 540 |
PULMONARY ALVEOLAR HAEMORRHAGE |
20 |
0.0036 |
| 541 |
POLYURIA |
29 |
0.0035 |
| 542 |
CONDITION AGGRAVATED |
1076 |
0.0035 |
| 543 |
CEREBRAL ISCHAEMIA |
18 |
0.0035 |
| 544 |
PRODUCT USE IN UNAPPROVED INDICATION |
859 |
0.0035 |
| 545 |
PETECHIAE |
36 |
0.0034 |
| 546 |
APLASTIC ANAEMIA |
18 |
0.0034 |
| 547 |
ERYTHEMA MULTIFORME |
32 |
0.0034 |
| 548 |
COLITIS ISCHAEMIC |
23 |
0.0034 |
| 549 |
LIPASE INCREASED |
26 |
0.0034 |
| 550 |
MOOD ALTERED |
92 |
0.0034 |
| 551 |
DECREASED ACTIVITY |
36 |
0.0033 |
| 552 |
BLEPHAROSPASM |
21 |
0.0033 |
| 553 |
ASPHYXIA |
27 |
0.0033 |
| 554 |
FOETAL GROWTH RESTRICTION |
20 |
0.0033 |
| 555 |
PREMATURE BABY |
99 |
0.0033 |
| 556 |
LEFT VENTRICULAR DYSFUNCTION |
22 |
0.0033 |
| 557 |
LUNG INFILTRATION |
29 |
0.0033 |
| 558 |
HAEMATOCRIT DECREASED |
65 |
0.0033 |
| 559 |
HYPERLIPIDAEMIA |
39 |
0.0033 |
| 560 |
TARDIVE DYSKINESIA |
92 |
0.0033 |
| 561 |
DERMATITIS ALLERGIC |
41 |
0.0033 |
| 562 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
57 |
0.0032 |
| 563 |
PLEURISY |
19 |
0.0032 |
| 564 |
PRODUCT ADMINISTRATION INTERRUPTED |
25 |
0.0032 |
| 565 |
HYPERSOMNIA |
91 |
0.0032 |
| 566 |
HEPATITIS |
81 |
0.0032 |
| 567 |
PHOTOPSIA |
20 |
0.0032 |
| 568 |
SLEEP DISORDER |
222 |
0.0031 |
| 569 |
HEPATIC FUNCTION ABNORMAL |
116 |
0.0031 |
| 570 |
LIVE BIRTH |
26 |
0.0031 |
| 571 |
HYPERBILIRUBINAEMIA |
32 |
0.0031 |
| 572 |
LACTIC ACIDOSIS |
100 |
0.0031 |
| 573 |
LYMPHOCYTE COUNT DECREASED |
54 |
0.0031 |
| 574 |
ENERGY INCREASED |
18 |
0.0030 |
| 575 |
RESPIRATION ABNORMAL |
21 |
0.0030 |
| 576 |
DEMENTIA |
85 |
0.0030 |
| 577 |
MUSCLE TWITCHING |
70 |
0.0030 |
| 578 |
VENTRICULAR TACHYCARDIA |
50 |
0.0030 |
| 579 |
ARRHYTHMIA |
143 |
0.0030 |
| 580 |
OBSESSIVE-COMPULSIVE DISORDER |
24 |
0.0030 |
| 581 |
HYPOGLYCAEMIA |
145 |
0.0030 |
| 582 |
ACUTE RESPIRATORY FAILURE |
57 |
0.0030 |
| 583 |
DIABETIC KETOACIDOSIS |
71 |
0.0030 |
| 584 |
HEMIPARESIS |
50 |
0.0029 |
| 585 |
INTERNATIONAL NORMALISED RATIO INCREASED |
84 |
0.0029 |
| 586 |
DECUBITUS ULCER |
24 |
0.0029 |
| 587 |
INTESTINAL PERFORATION |
33 |
0.0029 |
| 588 |
RED BLOOD CELL COUNT DECREASED |
84 |
0.0029 |
| 589 |
DRUG ERUPTION |
52 |
0.0029 |
| 590 |
POLYNEUROPATHY |
35 |
0.0029 |
| 591 |
DRUG INEFFECTIVE |
3836 |
0.0029 |
| 592 |
HEMIPLEGIA |
24 |
0.0029 |
| 593 |
MENTAL DISORDER |
125 |
0.0029 |
| 594 |
DISSOCIATION |
22 |
0.0029 |
| 595 |
CARDIOGENIC SHOCK |
41 |
0.0029 |
| 596 |
GAIT DISTURBANCE |
546 |
0.0028 |
| 597 |
WITHDRAWAL SYNDROME |
119 |
0.0028 |
| 598 |
BLADDER DISORDER |
28 |
0.0028 |
| 599 |
INCREASED APPETITE |
53 |
0.0028 |
| 600 |
HYPOKALAEMIA |
128 |
0.0028 |
| 601 |
TYPE 2 DIABETES MELLITUS |
93 |
0.0028 |
| 602 |
SUBARACHNOID HAEMORRHAGE |
28 |
0.0027 |
| 603 |
HYPERGLYCAEMIA |
100 |
0.0027 |
| 604 |
HYPOMAGNESAEMIA |
38 |
0.0027 |
| 605 |
FACE OEDEMA |
46 |
0.0027 |
| 606 |
NEUTROPHIL COUNT DECREASED |
111 |
0.0027 |
| 607 |
WEIGHT INCREASED |
608 |
0.0027 |
| 608 |
URINARY RETENTION |
90 |
0.0027 |
| 609 |
LOSS OF CONSCIOUSNESS |
345 |
0.0027 |
| 610 |
BLOOD UREA INCREASED |
45 |
0.0027 |
| 611 |
OXYGEN SATURATION DECREASED |
151 |
0.0027 |
| 612 |
COELIAC DISEASE |
26 |
0.0026 |
| 613 |
MITRAL VALVE INCOMPETENCE |
30 |
0.0026 |
| 614 |
BODY TEMPERATURE INCREASED |
54 |
0.0026 |
| 615 |
PALLOR |
72 |
0.0026 |
| 616 |
CLOSTRIDIUM DIFFICILE COLITIS |
28 |
0.0026 |
| 617 |
PROTEINURIA |
50 |
0.0026 |
| 618 |
SEPTIC SHOCK |
114 |
0.0026 |
| 619 |
SLEEP APNOEA SYNDROME |
50 |
0.0026 |
| 620 |
VENTRICULAR EXTRASYSTOLES |
27 |
0.0026 |
| 621 |
HYPERCHOLESTEROLAEMIA |
25 |
0.0026 |
| 622 |
INTENTIONAL DRUG MISUSE |
54 |
0.0026 |
| 623 |
PREMATURE DELIVERY |
41 |
0.0026 |
| 624 |
NERVOUS SYSTEM DISORDER |
80 |
0.0026 |
| 625 |
SPLENOMEGALY |
30 |
0.0026 |
| 626 |
PYREXIA |
886 |
0.0026 |
| 627 |
HICCUPS |
21 |
0.0026 |
| 628 |
OFF LABEL USE |
2208 |
0.0025 |
| 629 |
HEPATIC CYTOLYSIS |
32 |
0.0025 |
| 630 |
POOR QUALITY SLEEP |
54 |
0.0025 |
| 631 |
PERICARDITIS |
42 |
0.0025 |
| 632 |
DYSPHAGIA |
236 |
0.0025 |
| 633 |
ANGER |
84 |
0.0025 |
| 634 |
PLEURAL EFFUSION |
151 |
0.0025 |
| 635 |
LIVER FUNCTION TEST ABNORMAL |
72 |
0.0025 |
| 636 |
HEPATOCELLULAR INJURY |
35 |
0.0025 |
| 637 |
HALLUCINATION |
186 |
0.0025 |
| 638 |
MOUTH HAEMORRHAGE |
18 |
0.0025 |
| 639 |
PSEUDOMONAS INFECTION |
21 |
0.0024 |
| 640 |
GENERAL PHYSICAL HEALTH DETERIORATION |
283 |
0.0024 |
| 641 |
CRYING |
88 |
0.0024 |
| 642 |
BALANCE DISORDER |
209 |
0.0024 |
| 643 |
MALNUTRITION |
27 |
0.0024 |
| 644 |
HEPATIC ENZYME INCREASED |
164 |
0.0024 |
| 645 |
ACCIDENTAL OVERDOSE |
88 |
0.0024 |
| 646 |
BLOOD DISORDER |
19 |
0.0024 |
| 647 |
PRESCRIBED UNDERDOSE |
47 |
0.0024 |
| 648 |
BLOOD SODIUM DECREASED |
44 |
0.0023 |
| 649 |
ATRIOVENTRICULAR BLOCK |
18 |
0.0023 |
| 650 |
FEEDING DISORDER |
47 |
0.0023 |
| 651 |
MYOPATHY |
20 |
0.0023 |
| 652 |
CHOKING |
45 |
0.0023 |
| 653 |
PLATELET COUNT INCREASED |
30 |
0.0023 |
| 654 |
SEPSIS |
256 |
0.0023 |
| 655 |
DISSEMINATED INTRAVASCULAR COAGULATION |
32 |
0.0023 |
| 656 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
25 |
0.0023 |
| 657 |
ERECTILE DYSFUNCTION |
58 |
0.0023 |
| 658 |
FEAR |
60 |
0.0022 |
| 659 |
MOOD SWINGS |
71 |
0.0022 |
| 660 |
BLOOD POTASSIUM INCREASED |
36 |
0.0022 |
| 661 |
BONE MARROW FAILURE |
45 |
0.0022 |
| 662 |
MOVEMENT DISORDER |
71 |
0.0022 |
| 663 |
HYPERKALAEMIA |
77 |
0.0022 |
| 664 |
INTENTIONAL PRODUCT MISUSE |
192 |
0.0022 |
| 665 |
CHOLESTASIS |
42 |
0.0022 |
| 666 |
JOINT DISLOCATION |
23 |
0.0022 |
| 667 |
UROSEPSIS |
20 |
0.0022 |
| 668 |
PARALYSIS |
31 |
0.0022 |
| 669 |
VITAMIN D DEFICIENCY |
21 |
0.0022 |
| 670 |
PNEUMONIA |
690 |
0.0021 |
| 671 |
BEDRIDDEN |
28 |
0.0021 |
| 672 |
CYTOPENIA |
26 |
0.0021 |
| 673 |
LEUKAEMIA |
20 |
0.0021 |
| 674 |
LOSS OF LIBIDO |
19 |
0.0021 |
| 675 |
HYPOPHAGIA |
54 |
0.0021 |
| 676 |
WHITE BLOOD CELL COUNT DECREASED |
227 |
0.0021 |
| 677 |
DRUG INTOLERANCE |
202 |
0.0021 |
| 678 |
HEAD INJURY |
66 |
0.0021 |
| 679 |
PRODUCT USE ISSUE |
391 |
0.0021 |
| 680 |
BLOOD BILIRUBIN INCREASED |
56 |
0.0021 |
| 681 |
ABSCESS |
33 |
0.0021 |
| 682 |
ANXIETY |
587 |
0.0021 |
| 683 |
LYMPHADENOPATHY |
73 |
0.0021 |
| 684 |
PULMONARY CONGESTION |
27 |
0.0020 |
| 685 |
PREGNANCY |
41 |
0.0020 |
| 686 |
BLOOD TRIGLYCERIDES INCREASED |
36 |
0.0020 |
| 687 |
BODY TEMPERATURE DECREASED |
20 |
0.0020 |
| 688 |
CARDIOMYOPATHY |
30 |
0.0020 |
| 689 |
PRODUCT ADMINISTRATION ERROR |
41 |
0.0020 |
| 690 |
SUBDURAL HAEMATOMA |
29 |
0.0020 |
| 691 |
MYOCARDIAL ISCHAEMIA |
23 |
0.0020 |
| 692 |
EATING DISORDER |
43 |
0.0020 |
| 693 |
ARTERIOSCLEROSIS |
19 |
0.0020 |
| 694 |
CARDIOTOXICITY |
18 |
0.0020 |
| 695 |
RENAL FAILURE ACUTE |
85 |
0.0020 |
| 696 |
MEDICATION ERROR |
111 |
0.0020 |
| 697 |
THERAPEUTIC RESPONSE DECREASED |
120 |
0.0020 |
| 698 |
PRODUCT PRESCRIBING ERROR |
47 |
0.0020 |
| 699 |
PLATELET COUNT DECREASED |
210 |
0.0020 |
| 700 |
SKIN INFECTION |
22 |
0.0020 |
| 701 |
BRAIN NEOPLASM |
18 |
0.0020 |
| 702 |
PERSONALITY CHANGE |
18 |
0.0019 |
| 703 |
ACUTE KIDNEY INJURY |
295 |
0.0019 |
| 704 |
HAEMOGLOBIN DECREASED |
197 |
0.0019 |
| 705 |
CONTRAINDICATED PRODUCT ADMINISTERED |
58 |
0.0019 |
| 706 |
MEMORY IMPAIRMENT |
262 |
0.0019 |
| 707 |
HAEMATOMA |
49 |
0.0019 |
| 708 |
BLOOD CREATININE INCREASED |
122 |
0.0019 |
| 709 |
HEAD DISCOMFORT |
33 |
0.0019 |
| 710 |
SLUGGISHNESS |
19 |
0.0019 |
| 711 |
PULMONARY OEDEMA |
83 |
0.0019 |
| 712 |
RESPIRATORY DISORDER |
55 |
0.0018 |
| 713 |
CONJUNCTIVITIS |
34 |
0.0018 |
| 714 |
AMENORRHOEA |
32 |
0.0018 |
| 715 |
LIVER FUNCTION TEST INCREASED |
39 |
0.0018 |
| 716 |
RESTLESS LEGS SYNDROME |
33 |
0.0018 |
| 717 |
INSOMNIA |
480 |
0.0018 |
| 718 |
SKIN LESION |
49 |
0.0018 |
| 719 |
JOINT INJURY |
38 |
0.0018 |
| 720 |
DECREASED APPETITE |
413 |
0.0018 |
| 721 |
CANDIDA INFECTION |
30 |
0.0018 |
| 722 |
LYMPHOPENIA |
25 |
0.0018 |
| 723 |
MOUTH ULCERATION |
37 |
0.0018 |
| 724 |
FALL |
580 |
0.0017 |
| 725 |
POOR VENOUS ACCESS |
18 |
0.0017 |
| 726 |
RASH GENERALISED |
45 |
0.0017 |
| 727 |
MYELODYSPLASTIC SYNDROME |
25 |
0.0017 |
| 728 |
EMOTIONAL DISORDER |
53 |
0.0017 |
| 729 |
JAUNDICE |
46 |
0.0017 |
| 730 |
MUSCULOSKELETAL STIFFNESS |
148 |
0.0017 |
| 731 |
DEAFNESS |
44 |
0.0017 |
| 732 |
CENTRAL NERVOUS SYSTEM LESION |
23 |
0.0017 |
| 733 |
QUALITY OF LIFE DECREASED |
22 |
0.0016 |
| 734 |
DIABETES MELLITUS INADEQUATE CONTROL |
29 |
0.0016 |
| 735 |
ABNORMAL WEIGHT GAIN |
20 |
0.0016 |
| 736 |
OBSTRUCTIVE AIRWAYS DISORDER |
18 |
0.0016 |
| 737 |
DIABETES MELLITUS |
123 |
0.0016 |
| 738 |
HAEMORRHAGE INTRACRANIAL |
24 |
0.0016 |
| 739 |
OEDEMA |
87 |
0.0016 |
| 740 |
BLOOD CALCIUM DECREASED |
18 |
0.0016 |
| 741 |
BLOOD PRESSURE SYSTOLIC INCREASED |
31 |
0.0016 |
| 742 |
FRACTURE |
30 |
0.0016 |
| 743 |
ADVERSE REACTION |
21 |
0.0016 |
| 744 |
ABDOMINAL DISTENSION |
165 |
0.0016 |
| 745 |
MICTURITION URGENCY |
18 |
0.0016 |
| 746 |
RESPIRATORY TRACT INFECTION |
41 |
0.0016 |
| 747 |
NERVOUSNESS |
82 |
0.0016 |
| 748 |
MIGRAINE |
149 |
0.0016 |
| 749 |
LIVER DISORDER |
69 |
0.0016 |
| 750 |
INTENTIONAL PRODUCT USE ISSUE |
135 |
0.0015 |
| 751 |
HAEMATEMESIS |
39 |
0.0015 |
| 752 |
VOMITING |
720 |
0.0015 |
| 753 |
SECRETION DISCHARGE |
19 |
0.0015 |
| 754 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
30 |
0.0015 |
| 755 |
UPPER RESPIRATORY TRACT INFECTION |
70 |
0.0015 |
| 756 |
HYPERHIDROSIS |
195 |
0.0015 |
| 757 |
ISCHAEMIC STROKE |
27 |
0.0015 |
| 758 |
DEHYDRATION |
196 |
0.0015 |
| 759 |
DISABILITY |
29 |
0.0015 |
| 760 |
VERTIGO |
89 |
0.0015 |
| 761 |
HYPERCALCAEMIA |
18 |
0.0015 |
| 762 |
STAPHYLOCOCCAL INFECTION |
48 |
0.0015 |
| 763 |
BACTERIAL INFECTION |
27 |
0.0014 |
| 764 |
BLOOD PRESSURE DECREASED |
96 |
0.0014 |
| 765 |
SYNCOPE |
144 |
0.0014 |
| 766 |
ADVERSE DRUG REACTION |
129 |
0.0014 |
| 767 |
CEREBRAL INFARCTION |
35 |
0.0014 |
| 768 |
RASH ERYTHEMATOUS |
68 |
0.0014 |
| 769 |
FEMUR FRACTURE |
44 |
0.0014 |
| 770 |
BLISTER |
79 |
0.0014 |
| 771 |
HYPERTENSION |
296 |
0.0014 |
| 772 |
ANOREXIA |
18 |
0.0014 |
| 773 |
CEREBRAL HAEMORRHAGE |
50 |
0.0014 |
| 774 |
DRUG WITHDRAWAL SYNDROME |
121 |
0.0014 |
| 775 |
PRODUCT SUBSTITUTION ISSUE |
79 |
0.0014 |
| 776 |
DEEP VEIN THROMBOSIS |
89 |
0.0014 |
| 777 |
MUSCULAR WEAKNESS |
155 |
0.0014 |
| 778 |
ABDOMINAL PAIN |
315 |
0.0014 |
| 779 |
AMNESIA |
88 |
0.0014 |
| 780 |
WEIGHT DECREASED |
374 |
0.0013 |
| 781 |
EYE DISORDER |
44 |
0.0013 |
| 782 |
GASTROENTERITIS VIRAL |
24 |
0.0013 |
| 783 |
GINGIVAL BLEEDING |
18 |
0.0013 |
| 784 |
GASTROENTERITIS |
19 |
0.0013 |
| 785 |
DISEASE PROGRESSION |
154 |
0.0013 |
| 786 |
RENAL FAILURE |
172 |
0.0013 |
| 787 |
RENAL IMPAIRMENT |
108 |
0.0013 |
| 788 |
CONSTIPATION |
279 |
0.0013 |
| 789 |
EAR INFECTION |
33 |
0.0012 |
| 790 |
DRUG EFFECT INCOMPLETE |
45 |
0.0012 |
| 791 |
HAEMATURIA |
42 |
0.0012 |
| 792 |
URINARY TRACT INFECTION |
207 |
0.0012 |
| 793 |
VIRAL INFECTION |
40 |
0.0012 |
| 794 |
SENSORY DISTURBANCE |
19 |
0.0012 |
| 795 |
ANHEDONIA |
31 |
0.0012 |
| 796 |
DEVICE RELATED INFECTION |
18 |
0.0012 |
| 797 |
INFECTION |
169 |
0.0012 |
| 798 |
SKIN ULCER |
30 |
0.0012 |
| 799 |
ANAEMIA |
221 |
0.0012 |
| 800 |
EJECTION FRACTION DECREASED |
18 |
0.0012 |
| 801 |
INTESTINAL OBSTRUCTION |
43 |
0.0011 |
| 802 |
HERNIA |
22 |
0.0011 |
| 803 |
GAIT INABILITY |
38 |
0.0011 |
| 804 |
BLOOD CHOLESTEROL INCREASED |
53 |
0.0011 |
| 805 |
HOSPITALISATION |
174 |
0.0011 |
| 806 |
ANGIOEDEMA |
50 |
0.0011 |
| 807 |
HEART RATE INCREASED |
111 |
0.0011 |
| 808 |
THIRST |
20 |
0.0011 |
| 809 |
THERAPEUTIC RESPONSE UNEXPECTED |
50 |
0.0011 |
| 810 |
UNDERDOSE |
81 |
0.0011 |
| 811 |
NECK PAIN |
62 |
0.0011 |
| 812 |
CARDIAC FAILURE |
89 |
0.0011 |
| 813 |
GASTRITIS |
29 |
0.0011 |
| 814 |
POST PROCEDURAL COMPLICATION |
21 |
0.0011 |
| 815 |
PHOTOSENSITIVITY REACTION |
18 |
0.0011 |
| 816 |
DYSURIA |
40 |
0.0011 |
| 817 |
RASH |
473 |
0.0011 |
| 818 |
DIZZINESS |
535 |
0.0011 |
| 819 |
MUCOSAL INFLAMMATION |
28 |
0.0011 |
| 820 |
ABDOMINAL PAIN LOWER |
27 |
0.0011 |
| 821 |
PHOTOPHOBIA |
20 |
0.0011 |
| 822 |
OEDEMA PERIPHERAL |
129 |
0.0011 |
| 823 |
VISUAL ACUITY REDUCED |
35 |
0.0011 |
| 824 |
FEELING JITTERY |
20 |
0.0010 |
| 825 |
ASTHENIA |
394 |
0.0010 |
| 826 |
PANIC ATTACK |
38 |
0.0010 |
| 827 |
LOWER RESPIRATORY TRACT INFECTION |
47 |
0.0010 |
| 828 |
RASH MACULAR |
36 |
0.0010 |
| 829 |
NEPHROLITHIASIS |
47 |
0.0010 |
| 830 |
ABASIA |
25 |
0.0010 |
| 831 |
VISION BLURRED |
138 |
0.0010 |
| 832 |
BLOOD POTASSIUM DECREASED |
30 |
0.0010 |
| 833 |
ATRIAL FIBRILLATION |
97 |
0.0010 |
| 834 |
BONE DISORDER |
18 |
0.0010 |
| 835 |
COLITIS |
37 |
0.0010 |
| 836 |
CHOLELITHIASIS |
32 |
0.0010 |
| 837 |
MOBILITY DECREASED |
70 |
0.0010 |
| 838 |
GYNAECOMASTIA |
30 |
0.0010 |
| 839 |
PRODUCT AVAILABILITY ISSUE |
22 |
0.0010 |
| 840 |
PRODUCT PRESCRIBING ISSUE |
21 |
0.0010 |
| 841 |
FREQUENT BOWEL MOVEMENTS |
26 |
0.0010 |
| 842 |
PULMONARY EMBOLISM |
91 |
0.0010 |
| 843 |
CELLULITIS |
48 |
0.0010 |
| 844 |
ACUTE MYOCARDIAL INFARCTION |
28 |
0.0009 |
| 845 |
FOOT FRACTURE |
18 |
0.0009 |
| 846 |
FATIGUE |
719 |
0.0009 |
| 847 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
48 |
0.0009 |
| 848 |
CLOSTRIDIUM DIFFICILE INFECTION |
20 |
0.0009 |
| 849 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
41 |
0.0009 |
| 850 |
PULMONARY HYPERTENSION |
19 |
0.0009 |
| 851 |
ROAD TRAFFIC ACCIDENT |
38 |
0.0009 |
| 852 |
PRESYNCOPE |
22 |
0.0009 |
| 853 |
SKIN DISORDER |
30 |
0.0009 |
| 854 |
INFLUENZA LIKE ILLNESS |
74 |
0.0009 |
| 855 |
LUNG DISORDER |
44 |
0.0009 |
| 856 |
GASTROINTESTINAL DISORDER |
80 |
0.0009 |
| 857 |
MULTIPLE SCLEROSIS |
42 |
0.0009 |
| 858 |
OSTEOPOROSIS |
36 |
0.0009 |
| 859 |
DRY MOUTH |
71 |
0.0009 |
| 860 |
NIGHTMARE |
30 |
0.0009 |
| 861 |
FIBROMYALGIA |
21 |
0.0009 |
| 862 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
25 |
0.0009 |
| 863 |
ASCITES |
25 |
0.0008 |
| 864 |
RASH PAPULAR |
19 |
0.0008 |
| 865 |
DRUG ADMINISTRATION ERROR |
26 |
0.0008 |
| 866 |
ALOPECIA |
166 |
0.0008 |
| 867 |
FEBRILE NEUTROPENIA |
56 |
0.0008 |
| 868 |
HEART RATE IRREGULAR |
19 |
0.0008 |
| 869 |
DYSPEPSIA |
82 |
0.0008 |
| 870 |
HAEMORRHAGE |
87 |
0.0008 |
| 871 |
MALAISE |
363 |
0.0008 |
| 872 |
INJURY |
58 |
0.0008 |
| 873 |
INTERVERTEBRAL DISC PROTRUSION |
18 |
0.0008 |
| 874 |
CHILLS |
95 |
0.0008 |
| 875 |
STOMATITIS |
49 |
0.0008 |
| 876 |
DYSSTASIA |
23 |
0.0008 |
| 877 |
DISCOMFORT |
48 |
0.0008 |
| 878 |
NEURALGIA |
19 |
0.0008 |
| 879 |
BLOOD GLUCOSE DECREASED |
37 |
0.0008 |
| 880 |
NAUSEA |
608 |
0.0008 |
| 881 |
DIARRHOEA |
492 |
0.0008 |
| 882 |
SKIN DISCOLOURATION |
35 |
0.0008 |
| 883 |
INFLAMMATION |
39 |
0.0008 |
| 884 |
VISUAL IMPAIRMENT |
93 |
0.0007 |
| 885 |
INFLUENZA |
83 |
0.0007 |
| 886 |
INTENTIONAL DOSE OMISSION |
21 |
0.0007 |
| 887 |
EPISTAXIS |
55 |
0.0007 |
| 888 |
ADVERSE EVENT |
67 |
0.0007 |
| 889 |
CYSTITIS |
23 |
0.0007 |
| 890 |
LIP SWELLING |
24 |
0.0007 |
| 891 |
DEATH |
620 |
0.0007 |
| 892 |
HAEMOPTYSIS |
20 |
0.0007 |
| 893 |
DRUG DEPENDENCE |
113 |
0.0007 |
| 894 |
DYSPHONIA |
41 |
0.0007 |
| 895 |
HEADACHE |
437 |
0.0007 |
| 896 |
PRODUCTIVE COUGH |
33 |
0.0007 |
| 897 |
BLINDNESS |
28 |
0.0007 |
| 898 |
FEELING ABNORMAL |
163 |
0.0007 |
| 899 |
SWELLING FACE |
44 |
0.0007 |
| 900 |
ILLNESS |
69 |
0.0007 |
| 901 |
DRUG EFFECT DECREASED |
36 |
0.0007 |
| 902 |
MUSCULOSKELETAL PAIN |
35 |
0.0007 |
| 903 |
HYPERSENSITIVITY |
123 |
0.0007 |
| 904 |
PNEUMONITIS |
18 |
0.0007 |
| 905 |
UNEVALUABLE EVENT |
50 |
0.0007 |
| 906 |
GASTROOESOPHAGEAL REFLUX DISEASE |
53 |
0.0007 |
| 907 |
CHRONIC KIDNEY DISEASE |
50 |
0.0007 |
| 908 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
118 |
0.0007 |
| 909 |
MYALGIA |
111 |
0.0007 |
| 910 |
CEREBROVASCULAR ACCIDENT |
110 |
0.0006 |
| 911 |
PALPITATIONS |
76 |
0.0006 |
| 912 |
POLLAKIURIA |
27 |
0.0006 |
| 913 |
BONE DENSITY DECREASED |
20 |
0.0006 |
| 914 |
DYSPNOEA EXERTIONAL |
24 |
0.0006 |
| 915 |
CONTUSION |
61 |
0.0006 |
| 916 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
23 |
0.0006 |
| 917 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
22 |
0.0006 |
| 918 |
DYSPNOEA |
350 |
0.0006 |
| 919 |
EYE SWELLING |
23 |
0.0006 |
| 920 |
MALIGNANT NEOPLASM PROGRESSION |
63 |
0.0006 |
| 921 |
MUSCLE SPASMS |
112 |
0.0006 |
| 922 |
CHEST PAIN |
113 |
0.0006 |
| 923 |
IMPAIRED HEALING |
20 |
0.0006 |
| 924 |
ILL-DEFINED DISORDER |
37 |
0.0006 |
| 925 |
RASH PRURITIC |
33 |
0.0006 |
| 926 |
TRANSIENT ISCHAEMIC ATTACK |
20 |
0.0006 |
| 927 |
TINNITUS |
27 |
0.0006 |
| 928 |
COVID-19 |
103 |
0.0006 |
| 929 |
COUGH |
164 |
0.0006 |
| 930 |
ERYTHEMA |
119 |
0.0006 |
| 931 |
BLOOD PRESSURE INCREASED |
88 |
0.0006 |
| 932 |
BLOOD GLUCOSE INCREASED |
108 |
0.0006 |
| 933 |
ABDOMINAL PAIN UPPER |
117 |
0.0006 |
| 934 |
HAEMATOCHEZIA |
31 |
0.0006 |
| 935 |
ABDOMINAL DISCOMFORT |
93 |
0.0006 |
| 936 |
GASTRIC DISORDER |
19 |
0.0006 |
| 937 |
PRODUCT DOSE OMISSION ISSUE |
161 |
0.0005 |
| 938 |
PARAESTHESIA |
86 |
0.0005 |
| 939 |
OROPHARYNGEAL PAIN |
50 |
0.0005 |
| 940 |
GASTROINTESTINAL HAEMORRHAGE |
45 |
0.0005 |
| 941 |
BRONCHITIS |
39 |
0.0005 |
| 942 |
THERAPY CESSATION |
27 |
0.0005 |
| 943 |
INCORRECT DOSE ADMINISTERED |
120 |
0.0005 |
| 944 |
BACK PAIN |
121 |
0.0005 |
| 945 |
THERAPY INTERRUPTED |
37 |
0.0005 |
| 946 |
BONE PAIN |
30 |
0.0005 |
| 947 |
PAIN |
310 |
0.0005 |
| 948 |
FLATULENCE |
28 |
0.0005 |
| 949 |
RENAL DISORDER |
23 |
0.0005 |
| 950 |
BURNING SENSATION |
34 |
0.0005 |
| 951 |
SWELLING |
45 |
0.0005 |
| 952 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
34 |
0.0005 |
| 953 |
EXTRA DOSE ADMINISTERED |
19 |
0.0005 |
| 954 |
ASTHMA |
53 |
0.0005 |
| 955 |
HYPOAESTHESIA |
70 |
0.0005 |
| 956 |
CARDIAC DISORDER |
43 |
0.0005 |
| 957 |
WHEEZING |
27 |
0.0005 |
| 958 |
PRODUCT DOSE OMISSION |
29 |
0.0004 |
| 959 |
EYE PAIN |
25 |
0.0004 |
| 960 |
OCULAR HYPERAEMIA |
21 |
0.0004 |
| 961 |
NO ADVERSE EVENT |
80 |
0.0004 |
| 962 |
ECZEMA |
23 |
0.0004 |
| 963 |
NASOPHARYNGITIS |
81 |
0.0004 |
| 964 |
PRURITUS |
167 |
0.0004 |
| 965 |
PAIN IN EXTREMITY |
128 |
0.0004 |
| 966 |
INTERSTITIAL LUNG DISEASE |
21 |
0.0004 |
| 967 |
OSTEOARTHRITIS |
18 |
0.0004 |
| 968 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
82 |
0.0004 |
| 969 |
FLUSHING |
41 |
0.0004 |
| 970 |
NEUROPATHY PERIPHERAL |
38 |
0.0004 |
| 971 |
INFUSION RELATED REACTION |
26 |
0.0004 |
| 972 |
NASAL CONGESTION |
23 |
0.0004 |
| 973 |
ANAPHYLACTIC REACTION |
21 |
0.0004 |
| 974 |
SKIN EXFOLIATION |
32 |
0.0004 |
| 975 |
FEELING HOT |
23 |
0.0004 |
| 976 |
CATARACT |
22 |
0.0004 |
| 977 |
RHINORRHOEA |
23 |
0.0004 |
| 978 |
EMOTIONAL DISTRESS |
42 |
0.0003 |
| 979 |
PERIPHERAL SWELLING |
53 |
0.0003 |
| 980 |
CHEST DISCOMFORT |
35 |
0.0003 |
| 981 |
URTICARIA |
57 |
0.0003 |
| 982 |
MYOCARDIAL INFARCTION |
56 |
0.0003 |
| 983 |
ACNE |
23 |
0.0003 |
| 984 |
PSORIASIS |
39 |
0.0003 |
| 985 |
DRUG DOSE OMISSION |
49 |
0.0003 |
| 986 |
PRODUCT QUALITY ISSUE |
40 |
0.0003 |
| 987 |
SINUSITIS |
30 |
0.0003 |
| 988 |
JOINT SWELLING |
34 |
0.0003 |
| 989 |
ARTHRALGIA |
116 |
0.0003 |
| 990 |
CARDIAC FAILURE CONGESTIVE |
21 |
0.0003 |
| 991 |
ACCIDENTAL EXPOSURE TO PRODUCT |
21 |
0.0002 |
| 992 |
DRY SKIN |
21 |
0.0002 |
| 993 |
INJECTION SITE PAIN |
31 |
0.0001 |